Study of people with confirmed heart valve infection
Part of Heart & circulation clinical trials.
This is an observational study that follows people with confirmed infective endocarditis (a serious infection of the heart lining or heart valves). It may help doctors better understand the illness and improve care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have a confirmed diagnosis of infective endocarditis based on European criteria
- Your diagnosis must meet the study’s confirmation standards
- You must be willing to participate in the study
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study gathers information from patients with a heart infection called endocarditis to help doctors better understand and treat the condition. Anyone aged 16 or older with confirmed or suspected endocarditis who is being treated at Barts Heart Centre may be able to join.
This study looks at blood and other lab test results (“biomarkers”) to better predict what may happen to people with infective endocarditis, a serious infection of the heart lining or heart valves. Your information may help doctors estimate risk and choose care more safely and effectively.
This study is a registry, meaning it collects information about people who have had endocarditis (an infection of the heart's inner lining or valves). By joining, you help researchers learn more about this condition and improve future care.
This study tests a new way to find the cause of infective endocarditis, a serious heart infection. It may help doctors choose the right treatment faster.
This trial measures how your body handles certain intravenous antibiotics used for endocarditis, an infection of the heart valves. It may help doctors understand the best antibiotic dosing for people with valve infections.
This study collects information from people who have surgery for an infection in their heart (endocarditis). By looking at many patients across Europe, doctors hope to learn better ways to treat this condition.
Hear when a new Infective Endocarditis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.